The store will not work correctly when cookies are disabled.
2-(3,4-bis(N-methylsulfamoyl)-1H-pyrrol-1-yl)-N-(3,5-dimethylphenyl)acetamide
ID: ALA4761604
PubChem CID: 20921881
Max Phase: Preclinical
Molecular Formula: C16H22N4O5S2
Molecular Weight: 414.51
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CNS(=O)(=O)c1cn(CC(=O)Nc2cc(C)cc(C)c2)cc1S(=O)(=O)NC
Standard InChI: InChI=1S/C16H22N4O5S2/c1-11-5-12(2)7-13(6-11)19-16(21)10-20-8-14(26(22,23)17-3)15(9-20)27(24,25)18-4/h5-9,17-18H,10H2,1-4H3,(H,19,21)
Standard InChI Key: BYZLJWQEZWFJFE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
13.7767 -11.1807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4866 -10.7762 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.7814 -10.3637 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7272 -9.8723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9418 -9.0840 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.1518 -9.2923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9694 -10.1159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7866 -10.1159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0410 -9.3392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3780 -8.8570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7193 -9.3392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8185 -9.0877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4251 -9.6354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2026 -9.3839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2540 -10.4345 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8091 -9.9316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6342 -10.7294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2399 -11.2768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0184 -11.0255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1878 -10.2217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5807 -9.6778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0685 -12.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9644 -9.9676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7717 -8.2877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9944 -8.0355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8196 -11.5233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3385 -12.1838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 2 0
6 5 2 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
11 7 1 0
9 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
20 23 1 0
11 5 1 0
5 24 1 0
24 25 1 0
7 2 1 0
2 26 1 0
26 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 414.51 | Molecular Weight (Monoisotopic): 414.1032 | AlogP: 0.56 | #Rotatable Bonds: 7 |
Polar Surface Area: 126.37 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.74 | CX Basic pKa: ┄ | CX LogP: 0.88 | CX LogD: 0.86 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.61 | Np Likeness Score: -1.49 |
References
1. Liu Q,Miao Y,Wang X,Lv G,Peng Y,Li K,Li M,Qiu L,Lin J. (2020) Structure-based virtual screening and biological evaluation of novel non-bisphosphonate farnesyl pyrophosphate synthase inhibitors., 186 [PMID:31785819] [10.1016/j.ejmech.2019.111905] |